Business Context and Reporting Period
This Form 8-K reports on the 2022 Annual Meeting of Stockholders held by TRxADE HEALTH, Inc. on June 2, 2022. The filing details the voting results for director elections, auditor ratification, and executive compensation. The record date for the meeting was April 5, 2022.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial performance data. Revenue, profit, cash flow, margins, debt, and liquidity metrics are not provided in this document.
Material Changes
No material financial changes are reported in this filing. The document focuses solely on the outcomes of shareholder votes.
Outlook, Risks, and Voting Results
Meeting Participation: 6,576,133 shares (80% of outstanding voting stock) were present or voted, constituting a quorum.
Proposal 1: Election of Directors
- All five nominees were elected by a plurality of votes cast.
- Suren Ajjarapu: 4,713,068 For; 4,354 Withheld.
- Prashant Patel: 4,611,733 For; 105,689 Withheld.
- Donald G. Fell: 4,417,092 For; 300,330 Withheld.
- Charles L. Pope: 4,610,290 For; 107,132 Withheld.
- Christine L. Jennings: 4,612,926 For; 104,496 Withheld.
- Each director serves a one-year term.
Proposal 2: Ratification of Auditors
- MaloneBailey, LLP was ratified as the independent auditor for the fiscal year ending December 31, 2022.
- Result: 6,564,673 For; 9,451 Against; 2,009 Abstentions.
Proposal 3: Executive Compensation (Say-on-Pay)
- Non-binding approval of 2021 named executive officer compensation.
- Result: 4,582,945 For; 30,681 Against; 103,796 Abstentions.
Investor Verification Checklist
- Verify the full text of the Definitive Proxy Statement (Schedule 14A) filed on April 21, 2022, for detailed background on the director nominees and compensation policies.
- Confirm the total number of outstanding voting shares (8,181,041) as of the record date.
- Review subsequent filings for the company's financial performance, as this 8-K contains no financial data.